CAR-T Cells Therapy for Patients With Autoimmune Diseases

NCT07052565 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

18

Enrollment

OTHER_GOV

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis

Sponsor

Anhui Provincial Hospital